Open access
Distinct Prognostic Roles of Grade Group and Intraductal Carcinoma of the Prostate in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors
J. Ikeda
H. Taniguchi
Monta Inoue
Masuo Yuki
Takahiro Nakamoto
M. Taguchi
Seiji Shimada
T. Mishima
M. Yanishi
Katsunori Uchida
Hidefumi Kinoshita
Medicine
Abstract
The study aimed to evaluate the impact of grade group (GG) and intraductal carcinoma of the prostate (IDC‐P), as established prognostic factors, on clinical endpoints in metastatic hormone‐sensitive prostate cancer (mHSPC) patients treated with androgen receptor signaling inhibitors (ARSIs).